N/A
N=104
Interventional Study to Decrease Cardiovascular Risk in Women in Primary Health Care in South Croatia
Cardiovascular Risk Factor
Bottom Line
View on ClinicalTrials.gov: NCT03863210 ↗Enrolled (actual)
104
Serious AEs
0.0%
Results posted
Oct 2020
Primary outcome: Primary: Ten Year Risk of Cardiovascular Disease (CVD) — 2.9 percentage of risk
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- 60-minute lecture titled "Change of lifestyle and nutrition habits to reduce cardiovascular risk" (Other)
- Age
- Adult · 45+ yrs
- Sex
- Female
- Sponsor
- University of Split, School of Medicine
- Primary completion
- Sep 2014
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Ten Year Risk of Cardiovascular Disease (CVD) |
2.9 | — |
| PRIMARY Decisional Conflict (DC) |
27 | — |
| PRIMARY State Hope |
105 | — |
| SECONDARY Waist Circumference |
89 | — |
| SECONDARY Hips Circumference |
107 | — |
| SECONDARY Weight |
61 | — |
Summary
Patient education in lifestyle changes has a positive effect on health in individuals with cardiovascular (CV) risk Despite current positive evidence about lifestyle and dietary change in the prevention of CVD, the recommendations are still not consistently and optimally applied to women, particularly in relation to their menopausal status. More information is needed about factors that will support effective implementation of educational interventions for decreasing CV risk. The aim of our study was to analyze the effect of an educational intervention, presented as a 60-minute lecture in primary health care setting about CV risk factors to women with different menopausal status, in relation to their decisional conflict about their treatment for CV risk and hope that their health will improve according to desired expectations.
Eligibility Criteria
Inclusion Criteria
- female sex
- age 45 to 60 years
- one or more CV risk factors [overweight or obesity, i. e. body mass index (BMI) ≥25 kg/m2, and/or central obesity - waist circumference ≥88 cm, high blood pressure (systolic blood pressure ≥140 mm Hg and/or diastolic blood pressure ≥90 mm Hg), high blood cholesterol (≥5.2 mmol/L) and active smoking]
- participants on antihypertensive therapy were also included in the study
Exclusion Criteria
- current cardiovascular disease (CVD) (ischemic heart disease, peripheral artery disease, and stroke)
- malignant diseases
- serious systemic or mental diseases
Data sourced from ClinicalTrials.gov (NCT03863210). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.